The gene regulatory molecule GLIS3 in gastric cancer as a prognostic marker and be involved in the immune infiltration mechanism.

Yi Ding,Zehua Wang,Chen Chen,Chenxu Wang,Dongyu Li,Yanru Qin

Frontiers in oncology（2023）

引用 1|浏览7

暂无评分

摘要

GLIS3 is considered a novel STAD patient predictive biomarker. In addition, our research identifies possible genetic regulatory loci in the therapy of STAD.

查看译文

关键词

GLIS3,biomarker,gastric cancer,immune infiltration,prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要